欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2573/002
药品名称Aripiprazole STADA
活性成分
    • Aripiprazole monohydrate 400.0 mg
剂型Powder and solvent for prolonged-release suspension for injection
上市许可持有人STADA Arzneimittel AG, Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Greece (EL)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Germany (DE)
      Aripiprazol AL 400 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
    • Lithuania (LT)
      Aripiprazole STADA 400 mg milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai
    • Denmark (DK)
      Aripiprazole "Stada"
    • Estonia (EE)
    • Netherlands (NL)
    • Cyprus (CY)
      Aripiprazol /Stada 400 mg powder and solvent for prolonged-release suspension for injection
    • Austria (AT)
    • Romania (RO)
      Aripiprazol STADA 400 mg pulbere și solvent pentru suspensie injectabilă cu eliberare prelungită în seringă
    • France (FR)
    • Slovak Republic (SK)
    • Spain (ES)
    • Croatia (HR)
    • Portugal (PT)
    • Italy (IT)
许可日期2025/09/17
最近更新日期2025/11/26
药物ATC编码
    • N05AX12 aripiprazole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase